Daniel C McFarland1, Kelly M Shaffer2, Amy Tiersten3, Jimmie Holland2. 1. Division of Network Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harisson, NY, USA. 2. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. Department of Medicine, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Abstract
BACKGROUND: Patients with breast cancer have high rates of physical symptoms that negatively impact their quality of life. The relationship between women's perceptions of these physical symptoms and patient demographic and breast cancer characteristics is less well known. This study describes physical symptoms of patients with breast cancer and their relationship with patient characteristics. METHODS: Patients (n = 125) with breast cancer (stage 0-IV) completed questionnaires in a dedicated academic medical center breast cancer clinic. Patients reported demographics (age, race/ethnicity, marital status, and employment status) and disease characteristics (surgery type, receipt of chemotherapy, or antihormonal therapy). Patients reported whether they were bothered by any of the 22 physical problem list (PPL) variables from the distress thermometer and problem list. RESULTS: The median number of physical problems endorsed by patients was 3.0 (M = 3.43, SD = 3.42). Approximately one-fourth endorsed no physical symptoms while three-fourths reported at least 1 problem, and three-fifths endorsed 2 or more problems. Fatigue (40.0%), sleep (34.7%), skin dry/itchy (22.9%), pain (19.5%), and feeling swollen (19.5%) were most commonly reported. Age, race/ethnicity, marital status, employment status, and receipt of chemotherapy were associated with certain physical problems. Problems with breathing, eating, memory/concentration, nausea, and total number of endorsed PPL variables were associated with distress. CONCLUSION: The breast cancer population demonstrates heavy physical symptom burden with multiple physical problems that are related to overall functioning. Special attention should be given to the physical symptom burden of younger, nonwhite, unmarried, and unemployed patients. Future research should investigate the PPL of the distress thermometer and problem list with other measures of symptom burden.
BACKGROUND:Patients with breast cancer have high rates of physical symptoms that negatively impact their quality of life. The relationship between women's perceptions of these physical symptoms and patient demographic and breast cancer characteristics is less well known. This study describes physical symptoms of patients with breast cancer and their relationship with patient characteristics. METHODS:Patients (n = 125) with breast cancer (stage 0-IV) completed questionnaires in a dedicated academic medical center breast cancer clinic. Patients reported demographics (age, race/ethnicity, marital status, and employment status) and disease characteristics (surgery type, receipt of chemotherapy, or antihormonal therapy). Patients reported whether they were bothered by any of the 22 physical problem list (PPL) variables from the distress thermometer and problem list. RESULTS: The median number of physical problems endorsed by patients was 3.0 (M = 3.43, SD = 3.42). Approximately one-fourth endorsed no physical symptoms while three-fourths reported at least 1 problem, and three-fifths endorsed 2 or more problems. Fatigue (40.0%), sleep (34.7%), skin dry/itchy (22.9%), pain (19.5%), and feeling swollen (19.5%) were most commonly reported. Age, race/ethnicity, marital status, employment status, and receipt of chemotherapy were associated with certain physical problems. Problems with breathing, eating, memory/concentration, nausea, and total number of endorsed PPL variables were associated with distress. CONCLUSION: The breast cancer population demonstrates heavy physical symptom burden with multiple physical problems that are related to overall functioning. Special attention should be given to the physical symptom burden of younger, nonwhite, unmarried, and unemployed patients. Future research should investigate the PPL of the distress thermometer and problem list with other measures of symptom burden.
Authors: Achim Wöckel; L Schwentner; M Krockenberger; R Kreienberg; W Janni; M Wischnewsky; Kühn Thorsten; Flock Felix; Felberbaum Riccardo; M Blettner; S Singer Journal: Qual Life Res Date: 2017-04-06 Impact factor: 4.147
Authors: Lisa VanHoose; Lora L Black; Kimberly Doty; Dory Sabata; Philip Twumasi-Ankrah; Sarah Taylor; Rhonda Johnson Journal: Support Care Cancer Date: 2014-10-16 Impact factor: 3.603
Authors: Barbara L Andersen; Robert J DeRubeis; Barry S Berman; Jessie Gruman; Victoria L Champion; Mary Jane Massie; Jimmie C Holland; Ann H Partridge; Kate Bak; Mark R Somerfield; Julia H Rowland Journal: J Clin Oncol Date: 2014-04-14 Impact factor: 44.544
Authors: Eleshia J Morrison; Paul J Novotny; Jeff A Sloan; Ping Yang; Christi A Patten; Kathryn J Ruddy; Matthew M Clark Journal: Clin Lung Cancer Date: 2017-03-02 Impact factor: 4.840
Authors: Patricia I Jewett; Deanna Teoh; Sue Petzel; Heewon Lee; Audrey Messelt; Jeffrey Kendall; Dorothy Hatsukami; Susan A Everson-Rose; Anne H Blaes; Rachel I Vogel Journal: JCO Oncol Pract Date: 2020-02-24
Authors: J M Admiraal; J E H M Hoekstra-Weebers; C P Schröder; W Tuinier; G A P Hospers; Anna K L Reyners Journal: Support Care Cancer Date: 2019-09-11 Impact factor: 3.603
Authors: Maura K McCall; Mary Connolly; Bethany Nugent; Yvette P Conley; Catherine M Bender; Margaret Q Rosenzweig Journal: J Cancer Educ Date: 2020-06 Impact factor: 2.037
Authors: Xin Hu; Puneet K Chehal; Cameron Kaplan; Rebecca A Krukowski; Roy H Lan; Edward Stepanski; Lee Schwartzberg; Gregory Vidal; Ilana Graetz Journal: JAMA Netw Open Date: 2021-06-01
Authors: Deborah N N Lo-Fo-Wong; Hanneke C J M de Haes; Neil K Aaronson; Doris L van Abbema; Mathilda D den Boer; Marjan van Hezewijk; Marcelle Immink; Ad A Kaptein; Marian B E Menke-Pluijmers; Anna K L Reyners; Nicola S Russell; Manon Schriek; Sieta Sijtsema; Geertjan van Tienhoven; Mathilde G E Verdam; Mirjam A G Sprangers Journal: Psychooncology Date: 2019-12-16 Impact factor: 3.894